Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines
Authors:
- Jose Sullivan Lopez-GonzalezJLJose Sullivan Lopez-Gonzalez
- Heriberto Prado-GarciaHPHeriberto Prado-Garcia
- Dolores Aguilar-CazaresDADolores Aguilar-Cazares
- Juan A Molina-GuarnerosJMJuan A Molina-Guarneros
- Jorge Morales-FuentesJMJorge Morales-Fuentes
- Juan Jose MandokiJMJuan Jose Mandoki
- 1 March 2004
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 43 (3) , 275-283
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Lung Cancer—Where Are We Today?: Current Advances in Staging and Nonsurgical TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Lack of correlation between growth inhibition by TGF-β and the percentage of cells expressing type II TGF-β receptor in human non-small cell lung carcinoma cell linesLung Cancer, 2002
- Coumarin Metabolism, Toxicity and Carcinogenicity: Relevance for Human Risk AssessmentFood and Chemical Toxicology, 1999
- Experience With New Chemotherapeutic Agents in Non-small Cell Lung CancerChest, 1998
- An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarinJournal of Cancer Research and Clinical Oncology, 1994
- Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinomaJournal of Cancer Research and Clinical Oncology, 1994
- Treatment with coumarin to prevent or delay recurrence of malignant melanomaJournal of Cancer Research and Clinical Oncology, 1994
- Antitumour activity of coumarin in prostate and mammary cancer modelsJournal of Cancer Research and Clinical Oncology, 1994
- The effects of coumarin and suramin on the growth of malignant renal and prostatic cell linesJournal of Cancer Research and Clinical Oncology, 1994
- Growth-inhibitory effects of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin on human malignant cell lines in vitroJournal of Cancer Research and Clinical Oncology, 1994